About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Section of Rheumatology and Clinical Immunology
›
top-articles
Section of Rheumatology and Clinical Immunology
53
(top 2%)
papers
2.0K
(top 1%)
citations
18
(top 2%)
h
-index
37
(top 1%)
g
-index
59
all documents
2.3K
doc citations
826
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
PLoS ONE
2016
373
2
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
2019
213
3
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
2019
203
4
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
2019
164
5
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series
Annals of the Rheumatic Diseases
2017
141
6
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
2018
130
7
Systematic review of case reports of antiphospholipid syndrome following infection
Lupus
2016
105
8
Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis
Lupus
2018
105
9
Myositis as an adverse event of immune checkpoint blockade for cancer therapy
Seminars in Arthritis and Rheumatism
2019
90
10
Improving treatment adherence in patients with rheumatoid arthritis: what are the options?
International Journal of Clinical Rheumatology
2015
66
11
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees
Journal of Allergy and Clinical Immunology
2022
53
12
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy
Rheumatology
2019
49
13
Adverse Events in Cancer Immunotherapy
Advances in Experimental Medicine and Biology
2017
45
14
Arthritis risk with immune checkpoint inhibitor therapy for cancer
Current Opinion in Rheumatology
2019
36
15
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Nature Communications
2022
34
16
Checkpoint inhibitor-related renal vasculitis and use of rituximab
2020
32
17
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis
OncoImmunology
2021
32
18
Digital Patient Education and Decision Aids
Rheumatic Disease Clinics of North America
2019
28
19
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors
Supportive Care in Cancer
2020
28
20
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
Cancer Immunology, Immunotherapy
2021
27
21
Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol
Trials
2018
23
22
Cancer immunotherapy–related adverse events: causes and challenges
Supportive Care in Cancer
2020
22
23
A comprehensive scoping review to identify standards for the development of health information resources on the internet
PLoS ONE
2019
21
24
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors
Supportive Care in Cancer
2020
20
25
Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View
Cancers
2022
20
26
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials
Seminars in Arthritis and Rheumatism
2017
19
27
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)
Clinical and Experimental Rheumatology
2019
19
28
Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors
Blood Advances
2020
17
29
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities
Supportive Care in Cancer
2020
15
30
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
Supportive Care in Cancer
2020
14
31
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
2021
14
32
Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation
Archives of Osteoporosis
2018
13
33
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach
Seminars in Arthritis and Rheumatism
2021
13
34
Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report
Journal of Rheumatology
2017
12
35
A Case of Acquired Generalized Lipodystrophy Associated with Pembrolizumab in a Patient with Metastatic Malignant Melanoma
AACE Clinical Case Reports
2020
11
36
Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials
Seminars in Arthritis and Rheumatism
2019
9
37
Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy Is Associated With Decreased Fractures in Women With Breast Cancer
Journal of Bone and Mineral Research
2020
9
38
Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy
Clinical Rheumatology
2020
8
39
Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting System
Journal of Immunotherapy and Precision Oncology
2019
8
40
Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis
Journal of Rheumatology
2019
7
41
Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
Clinical Rheumatology
2020
7
42
Aromatase inhibitor-induced inflammatory myopathies: A case series
Joint Bone Spine
2022
6
43
Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists
Expert Review of Clinical Immunology
2019
5
44
Cyclophosphamide desensitization in patients with severe hypersensitivity reactions to bendamustine
Journal of Oncology Pharmacy Practice
2020
3
45
Ex Vivo Interferon Gamma Production by Peripheral Immune Cells Predicts Survival in Lung Adenocarcinoma
Clinical Lung Cancer
2019
2
46
Genetic determinants of adverse events in cancer patients receiving immune checkpoint inhibitors.
Journal of Clinical Oncology
2019
2
47
OP0197 Rheumatic and musculoskeletal adverse events associated with immune checkpoint inhibitors: data mining of the us food and drug administration adverse event reporting system
2018
2
48
Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults
JAMA - Journal of the American Medical Association
2018
1
49
Quality appraisal of educational websites about osteoporosis and bone health
Archives of Osteoporosis
2021
1
50
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Journal of Immunotherapy and Precision Oncology
2022
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.